Extended application of PGT-M strategies for small pathogenic CNVs

• Published in: Journal of assisted reproduction and genetics 2024-03, Vol.41 (3), p.739-750
• Main Authors: Hu, Xiao, Wang, Weili, Luo, Keli, Dai, Jing, Zhang, Yi, Wan, Zhenxing, He, Wenbin, Zhang, Shuoping, Yang, Lanlin, Tan, Qin, Li, Wen, Zhang, Qianjun, Gong, Fei, Lu, Guangxiu, Tan, Yue-Qiu, Lin, Ge, Du, Juan
• Format: Article
• Language: English
• Subjects: Abortion, Spontaneous - genetics; Amniotic fluid; Aneuploidy; Chromosomes; Disease; Embryos; Female; Fetuses; Genetic counseling; Genetic screening; Genetic testing; Genetic Testing - methods; Genetics; Genomes; Gynecology; Haplotypes; Hospitals; Human Genetics; Humans; Live Birth; Medicine; Medicine & Public Health; Patients; Polymorphism; Pregnancy; Pregnancy Rate; Preimplantation Diagnosis - methods; Prenatal diagnosis; Reproductive Medicine; Stem cells; Transplantation
• ISSN: 1058-0468; 1573-7330
• DOI: 10.1007/s10815-024-03028-6

Purpose The preimplantation genetic testing for aneuploidy (PGT-A) platform is not currently available for small copy-number variants (CNVs), especially those < 1 Mb. Through strategies used in PGT for monogenic disease (PGT-M), this study intended to perform PGT for families with small pathogenic CNVs. Methods Couples who carried small pathogenic CNVs and underwent PGT at the Reproductive and Genetic Hospital of CITIC-Xiangya (Hunan, China) between November 2019 and April 2023 were included in this study. Haplotype analysis was performed through two platforms (targeted sequencing and whole-genome arrays) to identify the unaffected embryos, which were subjected to transplantation. Prenatal diagnosis using amniotic fluid was performed during 18–20 weeks of pregnancy. Results PGT was successfully performed for 20 small CNVs (15 microdeletions and 5 microduplications) in 20 families. These CNVs distributed on chromosomes 1, 2, 6, 7, 13, 15, 16, and X with sizes ranging from 57 to 2120 kb. Three haplotyping-based PGT-M strategies were applied. A total of 89 embryos were identified in 25 PGT cycles for the 20 families. The diagnostic yield was 98.9% (88/89). Nineteen transfers were performed for 17 women, resulting in a 78.9% (15/19) clinical pregnancy rate after each transplantation. Of the nine women who had healthy babies, eight accepted prenatal diagnosis and the results showed no related pathogenic CNVs. Conclusion Our results show that the extended haplotyping-based PGT-M strategy application for small pathogenic CNVs compensated for the insufficient resolution of PGT-A. These three PGT-M strategies could be applied to couples with small pathogenic CNVs.